Medpace Holdings (MEDP) Accumulated Expenses (2015 - 2026)

Medpace Holdings (MEDP) has reported Accumulated Expenses for 12 consecutive years, with $451.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accumulated Expenses rose 39.43% year-over-year to $451.1 million; the trailing twelve-month figure through Jun 2026 stood at $451.1 million (up 39.43% YoY), and the FY2025 full-year result was $408.4 million, up 32.67% from the prior year.
• Accumulated Expenses climbed to $451.1 million in Q2 2026 per MEDP's latest filing, from $406.1 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $451.1 million in Q2 2026 and bottomed at $155.0 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $286.4 million across 5 years, with a median of $289.4 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Accumulated Expenses advanced 5.07% in 2024, then surged 41.93% in 2026.
• Over 5 years, Accumulated Expenses stood at $210.1 million in 2022, then surged by 39.42% to $293.0 million in 2023, then gained by 5.07% to $307.8 million in 2024, then jumped by 32.67% to $408.4 million in 2025, then increased by 10.45% to $451.1 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $451.1 million, $406.1 million, and $408.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.